Successful testing of a new refractory lining material developed by the Office of Fossil Energy’s National Energy Technology Laboratory (NETL) could lead to higher reliability and improved economics ...

Stivarga improved survival in refractory advanced gastric and esophagogastric junction cancer, reducing the risk for death by 30% and a median survival of 4.5 months. The 12-month survival rate was 19 ...

Activation of receptor tyrosine kinases (RTKs) by cytokines or growth factors initiates a protein-kinase-mediated cascade of molecular events that ultimately leads to control of cell growth and ...

Please provide your email address to receive an email when new articles are posted on . Patients with refractory advanced gastroesophageal cancer who received regorafenib vs. placebo had significantly ...

The refractory cement market is driven by its critical role in high-temperature applications across various industries. Refractory cement is essential for constructing and maintaining furnaces, kilns, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tizona Therapeutics, Inc., a privately held, clinical-stage company developing first-in-class cancer immunotherapies, announced today that its lead ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Refractories Market - Global Forecast to 2022" report to their offering. The global refractories market is projected to ...

H.C.Starck Solutions provides advanced refractory metal products that can be used in cancer treatment. The company offers tungsten and tungsten alloys, tantalum, niobium as well as molybdenum and ...

OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm). APHINITY trial (BIG ...

Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2). Phase I study of a new concept cancer ...